Miniatura

Fitxers

FuscoJP.pdf (514.31 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2018-07-01

Llicència de publicació

cc by (c) Fusco et al., 2018
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/172416

Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/cam4.1500

Resum

Single nucleotide polymorphisms (SNPs) may modulate individual susceptibility to carcinogens. We designed a genome-wide association study to characterize individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced non-small cell lung cancer (NSCLC), and we validated our results. We hypothesized that this strategy would enrich the frequencies of the alleles that contribute to the observed traits. We genotyped 2.37 million SNPs in 95 extreme phenotype individuals, that is: heavy smokers that either developed NSCLC at an early age (extreme cases); or did not present NSCLC at an advanced age (extreme controls), selected from a discovery set (n=3631). We validated significant SNPs in 133 additional subjects with extreme phenotypes selected from databases including >39,000 individuals. Two SNPs were validated: rs12660420 (p(combined)=5.66x10(-5); ORcombined=2.80), mapping to a noncoding transcript exon of PDE10A; and rs6835978 (p(combined)=1.02x10(-4); ORcombined=2.57), an intronic variant in ATP10D. We assessed the relevance of both proteins in early-stage NSCLC. PDE10A and ATP10D mRNA expressions correlated with survival in 821 stage I-II NSCLC patients (p=0.01 and p<0.0001). PDE10A protein expression correlated with survival in 149 patients with stage I-II NSCLC (p=0.002). In conclusion, we validated two variants associated with extreme phenotypes of high and low risk of developing tobacco-induced NSCLC. Our findings may allow to identify individuals presenting high and low risk to develop tobacco-induced NSCLC and to characterize molecular mechanisms of carcinogenesis and resistance to develop NSCLC.

Matèries

Càncer de pulmó, Genòmica

Matèries (anglès)

Lung cancer, Genomics

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

FUSCO, Juan pablo, PITA, Guillermo, PAJARES, María josé, ANDUEZA, Maria pilar, PATIÑO GARCÍA, Ana, TORRES, Juan p.  de, GURPIDE, Alfonso, ZULUETA, Javier, ALONSO, Rosario, ALVAREZ, Nuria, PIO, Ruben, MELERO, Ignacio, SANMAMED, Miguel f., RODRIGUEZ RUIZ, Maria, GIL BAZO, Ignacio, LÓPEZ PICAZO, José maría, CASANOVA, Ciro, BAZ DAVILA, Rebeca, AGUDO, Antonio, LOZANO, Maria dolores, GONZALEZ, Alvaro, SALA SERRA, Núria, ARDANAZ, Eva, BENITEZ, Javier, MONTUENGA, Luis m., GONZÁLEZ NEIRA, Anna, PÉREZ GRACIA, José luis. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer. _Cancer Medicine_. 2018. Vol. 7, núm. 7, pàgs. 3474-3483. [consulta: 21 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/172416]

Exportar metadades

JSON - METS

Compartir registre